Explore All Access
Check if your research matches the topics covered in Antiviral Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Antiviral Therapy : Impact Factor & More
eISSN: 2040-2058pISSN: 1359-6535
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Antiviral Therapy is a peer-reviewed medical journal published by International Medical Press. It publishes primary papers and reviews on all aspects of the clinical development of antiviral drugs, including clinical trial results, drug resistance, viral diagnostics, drug safety, pharmacoepidemiology, and vaccines. Antiviral Therapy is an official publication of the International Society for Antiviral Research. Less
Antiviral Therapy Key Metrics
CiteScore 
5.1
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.62
Topics Covered on Antiviral Therapy
Viral load
Hepatitis B
Chronic hepatitis
Genotype
Ribavirin
Sofosbuvir
Severe acute respiratory syndrome coronavirus
Entecavir
Postmenopausal women
Low molecular weight heparin
Hepatitis b surface antigen
Hepatitis C
Cirrhosis
Treatment modification
Hepatitis C virus genotype
Oseltamivir
Lamivudine
Diabetes monitoring
Salvage therapy
Influenza a
Antiviral Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1996 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Antiviral Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Antiviral Therapy
Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase in silico approach.
- 1 Dec 2024
- Antiviral therapy
Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohort.
- 1 Dec 2024
- Antiviral therapy
Analysis of risk factors and prediction model construction for varicella encephalitis in children: A retrospective cohort study.
- 1 Oct 2024
- Antiviral therapy
Antiviral potential of phenolic compounds against HSV-1: In-vitro study
- 23 Sep 2024
- Antiviral Therapy
Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study.
- 11 Sep 2024
- Antiviral therapy
Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort.
- 1 Aug 2024
- Antiviral therapy
Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase in silico approach.
- 1 Dec 2024
- Antiviral therapy
Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohort.
- 1 Dec 2024
- Antiviral therapy
Analysis of risk factors and prediction model construction for varicella encephalitis in children: A retrospective cohort study.
- 1 Oct 2024
- Antiviral therapy
Antiviral potential of phenolic compounds against HSV-1: In-vitro study
- 23 Sep 2024
- Antiviral Therapy
Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study.
- 11 Sep 2024
- Antiviral therapy
Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort.
- 1 Aug 2024
- Antiviral therapy
Compare Similar Journals with Antiviral Therapy
Select Journals to Compare with Antiviral Therapy
Total journals - 8
You can select up to 3 Journals at a time
Open Forum Infectious Diseases
Publisher: OXFORD UNIV PRESS INC
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Journal of Viral Hepatitis
Publisher: WILEY
AIDS
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Journal of Hepatology
Publisher: ELSEVIER
Clinical Infectious Diseases
Publisher: OXFORD UNIV PRESS INC
BMC Infectious Diseases
Publisher: BMC
International Journal of Infectious Diseases
Publisher: ELSEVIER SCI LTD
0 Journals Selected to compare with
Antiviral Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Antiviral Therapy
How long has Antiviral Therapy been actively publishing? 
Antiviral Therapy has been in operation since 1996 till date.
What is the publishing frequency of Antiviral Therapy?
Antiviral Therapy published with a Bi-monthly frequency.
How many articles did Antiviral Therapy publish last year?
In 2024, Antiviral Therapy publsihed 11 articles.
What is the eISSN & pISSN for Antiviral Therapy?
For Antiviral Therapy, eISSN is 2040-2058 and pISSN is 1359-6535.
What is Citescore for Antiviral Therapy?
Citescore for Antiviral Therapy is 5.1.
What is SNIP score for Antiviral Therapy?
SNIP score for Antiviral Therapy is 0.62.
What is the SJR for Antiviral Therapy?
SJR for Antiviral Therapy is Q2.
Who is the publisher of Antiviral Therapy?
SAGE PUBLICATIONS LTD is the publisher of Antiviral Therapy.
